Alex Haissl, Rothschild and Redburn analyst, recently explained the rationale behind his Sell rating and $175 price target on ...
Tech Xplore on MSN
AI could make it easier to create bioweapons that bypass current security protocols
Artificial intelligence is transforming biology and medicine by accelerating the discovery of new drugs and proteins and making it easier to design and manipulate DNA, the building blocks of life. But ...
The Register on MSN
Startups binge on AI while big firms sip cautiously, study shows
Better hope that bubble doesn't pop The Andreessen Horowitz venture capital firm (aka A16z) crunched startup spending data and found young firms stuffing AI into everything, while bigger businesses ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback